Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey
Open Access
- 25 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 32 (9), 1777-1784
- https://doi.org/10.1007/s00198-021-05864-z
Abstract
Summary To compare the diagnosis andtreatment rates of osteoporosis and diabetes in Korea, a nationwide database was used. The results showed that although osteoporosis management is improving, it is still lower compared with that of diabetes; thus, further efforts are needed in this regard. Introduction This study aimed to re-evaluate the diagnosis and treatment of osteoporosis from the KNHANES 2016–2017 and compare the temporal change of the rate with those of diabetes as another prevalent chronic disease in South Korea. Methods The prevalence of osteoporosis in 2016 was estimated using the previous data classified by age groups (50–59,60–69, and ≥70years) and the 2016 Korean census data. The physician diagnosis and treatment rates of osteoporosis in adults aged ≥50years were estimated using the 2016–2017 KNHANES data. The physician diagnosis and treatment rates of diabetes were evaluated using the KNHANES 2008–2009 and 2016–2017 data. Results The estimated physician diagnosisrate of osteoporosis increased from 29.9% in females and 5.8% in males in 2008–2009 to 62.8% in females and 22.8% in males in 2016–2017. The treatment rate for the estimated total number of patients with osteoporosis increased from 14.4% in females and 3.8% in males in 2008–2009 to 32.2% in females and 9.0% in males in 2016–2017. An increasing trend in the estimated treatment rateof physician-diagnosed osteoporosis patients was not observed (48.3% [2008–2009] vs 51.5% [2016–2017] in females; 42.6% [2008–2009] vs 42.2% [2016–2017] in males). The physician diagnosis and treatment rates of diabetes were considerably better and more stable than those of osteoporosis. Conclusion Osteoporosis management in South Korea is improving but is insufficient compared with diabetes management. More extensive efforts are needed to improve the diagnosis and treatment rates of osteoporosis.Keywords
Funding Information
- Yuhan Corporation
This publication has 20 references indexed in Scilit:
- Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national StudyThe American Journal of Medicine, 2015
- Association between the awareness of osteoporosis and the quality of care for bone health among Korean women with osteoporosisBMC Musculoskeletal Disorders, 2014
- The Asia-Pacific Regional Audit-Epidemiology, costs, and burden of osteoporosis in India 2013: A report of International Osteoporosis FoundationIndian Journal of Endocrinology and Metabolism, 2014
- Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysisJournal of Bone and Mineral Research, 2013
- Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010Diabetes & Metabolism Journal, 2013
- The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: The Korea National Health and Nutrition Examination Survey 2008–2009Journal of Bone and Mineral Research, 2012
- National Screening Program for Transitional Ages in Korea: A New Screening for Strengthening Primary Prevention and Follow-up CareJournal of Korean Medical Science, 2012
- National Screening Program for the Transitional Ages in KoreaJournal of the Korean Medical Association, 2010
- Prevalence and Management of Diabetes in Korean AdultsDiabetes Care, 2009
- Osteonecrosis of the Jaw and BisphosphonatesThe New England Journal of Medicine, 2005